The clinic states that it does not prescribe to travelers or does not hand out the medicine. Listed to save you a wasted trip.
What we verified
Each item shows the source and the date we checked the clinic's official site. Items without evidence are marked 'Unverified'.
- GLP-1 (Mounjaro) self-pay treatment
- YesSource: fukuoka-chuoh-biyo.com (new window) · Checked 2026-11-14
- Accepts visitors
- Unverified
- Korean support
- Unverified
- Same-day visit
- Unverified
- Hotel delivery
- NoSource: fukuoka-chuoh-biyo.com (new window) · Checked 2026-11-14
- In-clinic pickup
- No
- English prescription / letter
- Unverified
Prices published by the clinic
Copied from the clinic's site. Consultation and delivery fees may be extra; prices change.
| Item | JPY | Tax | Checked |
|---|---|---|---|
| マンジャロ 2.5mg 1本(院内注射) | ¥5,500 | incl. | 2026-11-14 · Source (new window) |
| マンジャロ 5mg 1本(院内注射) | ¥11,000 | incl. | 2026-11-14 · Source (new window) |
| 初診料 | ¥2,200 | incl. | 2026-11-14 · Source (new window) |
| 看護師注射 1回 | ¥3,300 | incl. | 2026-11-14 · Source (new window) |
Risks to know
GLP-1 injections commonly cause nausea, vomiting, diarrhea and constipation; rare reports include acute pancreatitis, hypoglycemia and vision problems (NAION). In Japan, Mounjaro is approved for type 2 diabetes only; weight-management use is off-label. Medicines prescribed abroad do not appear in Korea's DUR records and are hard to cover under its adverse-reaction relief scheme.
SushiMedi does not advertise clinics or medicines and does not refer patients. Treatment decisions are made by the local doctor. Medicines prescribed abroad are not covered by Korea's adverse-reaction relief scheme. Follow MFDS and Korea Customs rules when bringing medicines home.